Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04357873
Title Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations (PEVOsq)
Acronym PEVOsq
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut de Cancérologie de l'Ouest - Site Paul Papin Angers France Details
Institut Bergonié Bordeaux France Details
Centre François Baclesse Caen France Details
Centre Jean Perrin Clermont-Ferrand France Details
Centre George François Leclerc Dijon France Details
Centre Oscar Lambret Lille France Details
Centre Léon Bérard Lyon France Details
Institut de Cancérologie de Lorraine Nancy France Details
Institut de Cancérologie de l'Ouest (site René Gauducheau) Nantes France Details
Institut Curie Paris France Details
Centre Hospitalier Lyon Sud - Hospices Civils de Lyon Pierre-Bénite France Details
Institut Godinot Reims France Details
Centre Paul Strauss Strasbourg France Details
Institut Claudius Regaud Toulouse France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field